Peter Schellongowski is an Associate Professor of Medicine and Senior Intensivist in the ELSO ECMO center ICU 13.i2 of the Department of Medicine I at the Medical University of Vienna, Austria (ELSO ECMO center).
His clinical and scientific focus are different aspects of critically ill hemato-oncologic and other immunosuppressed patients as well as ARDS management including extracorporeal gas exchange techniques.
He is co-founder and coordinator of the Austrian-German initiative ‘Intensive Care in Haematologic and Oncologic Patients (iCHOP)’.
Along with coordinating the ‘Registry for Critically Ill Cancer Patients of the iCHOP Initiative’ he also heads the ESICM-endorsed YELENNA Study of the ‘Caring for critically ill immunocompromised patients (Nine-I)’ study group on cancer patients with ARDS.
He currently serves as National Representative to the ESICM and UEMS, on the Euro ELSO Scientific Committee, where he coordinates the newly established webinar program, as well as on the ELSO Scientific Overview Committee.